NCT01713738 Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP) Status COMPLETED Phase PHASE1/PHASE2
NCT01706107 Canadian Multicenter Observational Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis Participants Status TERMINATED Phase N/A
NCT01703988 An Open-label Safety, Tolerability and Dose-Range Finding Study of Multiple Doses of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy Status COMPLETED Phase PHASE1/PHASE2
NCT01689116 Multiple-Dose Study of Effect of Bardoxolone Methyl on QT/QTC Interval Volunteers Status COMPLETED Phase PHASE1
NCT01677572 Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease Status TERMINATED Phase PHASE1
NCT01656148 FAME - Fampyra Outcome Measures Study: a Study of Different Outcome Measures on the Effect of Fampyra Status COMPLETED Phase PHASE4
NCT01655186 A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Effects of Bardoxolone Methyl on Body Composition in Patients With Stage 4 Chronic Kidney Disease and Type 2 Diabetes Mellitus Status WITHDRAWN Phase PHASE2
NCT01652937 BIIB057 in Subjects With Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs Status WITHDRAWN Phase PHASE2
NCT01646840 Study Of The PF-04958242 Blood Concentrations Of A Capsule Formulation Of PF-04958242 Compared To A Solution Formulation Status COMPLETED Phase PHASE1
NCT01632449 Study in Healthy Volunteers to Establish the Bioequivalence of Two Different Manufacturers. Status COMPLETED Phase PHASE1
NCT01626248 Analysis of Lymphocyte Cell Surface Adhesion Marker Expression in Natalizumab Population With Active Control Status COMPLETED Phase N/A
NCT01610310 Peginterferon Beta-1a (BIIB017) Autoinjector Pharmacokinetic Study in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01598363 An Open-Label Study of the Effect of Bardoxolone Methyl on the Single Dose Pharmacokinetics of Digoxin and Rosuvastatin in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01597297 Exploratory Study to Assess the Effect of Fampridine (BIIB041) on Walking Ability and Balance in Participants With Multiple Sclerosis. Status COMPLETED Phase PHASE2
NCT01591551 NAPS-MS: NAtalizumab Effects on Parameters of Sleep in Patients With Multiple Sclerosis Experiencing Fatigue or Sleepiness Status COMPLETED Phase PHASE4